Menopause

Addressing women's health could unlock US$100bn by 2030 in the US alone, a new report has found. The World Economic Forum has published its Women's Health Investment Outlook to highlight undercapitalised opportunities in women's health. A Boston Consulting Group analysis cited in the report estimates that treating four major conditions that disproportionately affect women could [...]

Obesity and oestrogen-based medicines together raise blood clot risk in premenopausal women, research finds. The study explains how these factors combine to amplify thrombotic risk (dangerous blood clots) and offers insight to improve care for people already at higher risk, including those with cancer. Researchers found that thrombosis risk rises sharply in premenopausal women with [...]

The first NHS women's health hub will open in Wales before the end of January, officials have said. Hubs will be in place in each health board area by early March. They are a key commitment in the NHS-led Women's Health Plan and will provide integrated services focused on three priorities: menstrual health, contraception and [...]

Plans to eliminate cervical cancer by 2040 and transform gynaecology services, ending long waits, feature in the second phase of Scotland’s women's health plan. This phase is backed by more than £2.4m to cut gynaecology waits, taking total investment in gynaecology services to almost £13m this year. Scotland’s first women's health plan was published in [...]

A global menopause heart health study has won US$10m to launch the largest trial to detect silent artery changes and test earlier prevention. The SHE-HEALS study, led by BHF Professor Ziad Mallat at the University of Cambridge and Professor Martha Hickey at the University of Melbourne, will track arterial changes starting in perimenopause that drive [...]

Menopause hormone therapy is not strongly linked to dementia, a review of health data from over one million women reports. The systematic review, commissioned by the World Health Organization, examined links between cognitive health and hormone replacement therapy (HRT). The WHO currently provides no specific guidance on dementia and HRT, despite recent controversy around the [...]

Pomelo Care has raised US$92m in Series C funding at a US$1.7bn valuation as it expands its virtual maternity model into wider women's and children's healthcare. The New York-based company, which says it now covers nearly 7 per cent of US births, plans to use the funding to extend its model beyond maternity into reproductive [...]

By Olga Melita, founder, NeuroScent In the East, menopause is not feared - it is revered. It is known as The Second Spring - a time when a woman’s vital energy, once directed outward toward nurturing, creating, building and holding space for others, begins to return inward. This is not the end of [...]

Megestrol, a hot flush drug for breast cancer patients, may also curb tumours when added to standard hormone therapy, an early trial has found. The PIONEER trial tested megestrol acetate, a synthetic form of progesterone, alongside anti-oestrogen treatment in post-menopausal women with ER-positive breast cancer. After two weeks, patients on the combination saw greater falls [...]

Flex partners with Clue to make Clue Plus eligible for HSA and FSA spending in the US, letting users pay for menstrual health tools with pre-tax funds. HSAs and FSAs are US pre-tax accounts for eligible health costs. Announced on 16 December 2025, the move makes Clue Plus available via these benefits, with Flex citing [...]